Direxion Daily S&P Biotech Bear 3X ETF
LABD
LABD
12 hedge funds and large institutions have $9.23M invested in Direxion Daily S&P Biotech Bear 3X ETF in 2017 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 4 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more ownership
Funds ownership: →
0% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 2
0% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 4
Holders
12
Holding in Top 10
–
Calls
$1.68M
Puts
$628K
Top Buyers
| 1 | +$2.5M | |
| 2 | +$2.14M | |
| 3 | +$1.3M | |
| 4 |
VF
Virtu Financial
New York
|
+$1.14M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$139K |
Top Sellers
| 1 | -$5.69M | |
| 2 | -$368K | |
| 3 | -$269K | |
| 4 |
CG
Cutler Group
San Francisco,
California
|
-$9.96K |
| 5 |
CT
CMT Trading
Chicago,
Illinois
|
-$9.96K |